Senior Vice President of Worldwide Business Development, Pfizer Inc.
Doug Giordano is a Senior Vice President in Pfizer’s Worldwide Business Development Group, where he is responsible for leading Pfizer’s evaluation, negotiation and execution of product licensing, partnerships and M&A transactions.
Over the past eleven years, Doug has led teams responsible for Pfizer acquisitions, product collaborations/licensing and Pfizer’s IPO/split out of Zoetis. Before joining Pfizer’s Worldwide Business Development group in 2007, Doug held positions of increasing responsibility within Pfizer’s U.S. Pharmaceuticals commercial strategy and business development team. Before his U.S. pharmaceuticals operating role, Doug worked in a mergers and acquisitions role within Pfizer’s Medical Technology Group. Prior to his role with the Medical Technology Group, Doug held positions within Pfizer’s U.S. Pharmaceutical Group in finance and global manufacturing. Prior to joining Pfizer, Doug was a consultant at Booz, Allen & Hamilton. He currently serves on the Board of Directors of ICU Medical and Viiv Healthcare.
Doug earned a bachelor’s degree in biomedical engineering from Duke University and an MBA from Cornell University’s Johnson School of Business.